Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 28.76% vs -11.83% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 121.40% vs -32.46% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 17.69% vs 97.09% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 146.45% vs -15.94% in Mar 2024
Compare Profit and Loss Results of Jagsonpal Pharma
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
268.00
635.00
-367.00
-57.80%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
268.00
635.00
-367.00
-57.80%
Expenditure (Ex Depriciation)
Stock Adjustments
-2.00
-31.00
29.00
93.55%
Raw Materials Consumed
98.00
480.00
-382.00
-79.58%
Power & Fuel Cost
0.00
5.00
-5.00
-100.00%
Employee Cost
70.00
32.00
38.00
118.75%
Operating Expenses
0.00
15.00
-15.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
24.00
7.00
17.00
242.86%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
2.00
-2.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
217.00
544.00
-327.00
-60.11%
Operating Profit (PBDIT) excl Other Income
51.00
91.00
-40.00
-43.96%
Other Income
8.00
3.00
5.00
166.67%
Operating Profit (PBDIT)
59.00
94.00
-35.00
-37.23%
Interest
0.00
39.00
-39.00
-100.00%
Profit before Depriciation and Tax
58.00
55.00
3.00
5.45%
Depreciation
8.00
7.00
1.00
14.29%
Profit Before Taxation & Exceptional Items
50.00
47.00
3.00
6.38%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
69.00
47.00
22.00
46.81%
Provision for Tax
14.00
14.00
0.00
0.00%
Profit After Tax
55.00
33.00
22.00
66.67%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
104.00
63.00
41.00
65.08%
Profit Available for appropriations
159.00
97.00
62.00
63.92%
Appropriations
159.00
97.00
62.00
63.92%
Equity Dividend (%)
125%
7%
118.00
Earnings Per Share
8.26
68.01
-59.75
-87.85%
Profit And Loss - Net Sales
Net Sales 268.72 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 28.76% vs -11.83% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 51.07 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 121.40% vs -32.46% in Mar 2024
Profit And Loss - Interest
Interest 0.96 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 17.69% vs 97.09% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 55.36 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 146.45% vs -15.94% in Mar 2024
